Milbank LLP is advising the financing sources on Goldman Sachs Asset Management Division’s acquisition of a controlling stake in leading European specialty pharmaceuticals company Norgine BV.
Norgine has over 1,500 employees, with a presence in 16 European countries as well as Australia and New Zealand. Norgine has brought transformative medicines to patients for over a century.
The Milbank team is led by European Leveraged Finance/Capital Markets partner Sarbajeet Nag, and associates Peetra Anderson-Figueroa, Suktika Banerjee, Bie Cookey and Linda Mahlangu.
Allen & Overy is acting as counsel to Goldman Sachs Asset Management Division.
